This indicates a switch in the function of MYB during BPDCN leukemogenesis, from cooperative regulator of dendritic lineage genes in normal pDCs to direct regulator of cell cycle genes in BPDCN. Here, MYB is linked to CD4+/CD56+ hematodermic neoplasm.